OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
The HCPLive deep vein thrombosis page is a resource for medical news and expert insights on DVT. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.
February 01, 2022
Investigators noted that clinically relevant risks could not be excluded with certainty despite not seeing a statistically significant increase in corresponding risks for more rare and severe thrombotic outcomes.
July 09, 2021
A higher proportion of patients with immune-mediated diseases experienced ≥1 thromboembolic events at baseline compared to those without an IMD.
April 19, 2021
A new study finds patients with atrial fibrillation or venous thromboembolism were at higher risk of increased bleeding and hospitalization when treated with combination DOAC and aspirin.
April 15, 2021
An expert discusses the continued need to clarify COVID-19-related thrombosis risks as well as ensuring patients receive the most accurate information.
Maria DeSancho, MD, talks personal experiences with patients, vaccine hesitancy, mRNA versus adenovirus technology, risks and types of thrombosis, and more.
October 29, 2020
Tunneled catheters resulted in lower rates of deep vein thrombosis when compared to PICCs.
September 17, 2020
The rate of adverse events was higher in patients suffering from both deep vein thrombosis and pulmonary embolisms than it was in just patients with DVT.
July 31, 2020
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
July 30, 2020
A new systematic review and meta-analysis challenges the notion that preventing VTE is associated reduced mortality risk.
July 24, 2020
New findings evidences the device commonly used treatment in patients with VTE—despite its association with potentially new DVT development or existing DVT propagation.